Thyrotropin receptor antibody and bone turnover markers in patients with newly-diagnosed Graves' disease

被引：0
|
作者：
樊亚亚 [1 ]
机构：
[1] Dept Endocrinol,The 1st Affil Hosp,Zhengzhou University
来源：
China Medical Abstracts (Internal Medicine) | 2022年 / 39卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R581 [甲状腺疾病];
学科分类号：
1002 ; 100201 ;
摘要：
Objective To investigate the correlation between the level of thyrotropin receptor antibody (TRAb) and bone turnover markers (BTMs) in patients with newlydiagnosed Graves’disease (GD). Methods The clinical data of GD patients who were newly-diagnosed in the First Affiliated Hospital of Zhengzhou University from October 2016 to June 2021 were collected,including free triiodothyronine (FT3),free thyroxine (FT4),thyroid stimulating hormone, thyroid related antibodies,N-terminal procollagen of type I collagen (PINP),N-terminal osteocalcin (N-MID), β-cross-linked C-telopeptide of type I (β-CTX),blood lipid and renal function,etc.
引用
收藏
页码：154 / 155
页数：2
相关论文
共 50 条
  • [31] NEWLY-DIAGNOSED PARKINSONS-DISEASE - A THERAPEUTIC UPDATE
    PLEET, AB
    GERIATRICS, 1992, 47 (01) : 24 - 29
  • [32] Risk Factors and Prognosis of Extramedullary Disease in Newly-Diagnosed Multiple Myeloma Patients
    Gunes, Ebru K. I. L. I. C.
    Bulduk, Tuba
    Dumludag, Burak
    Zengin, Haydar
    Yildirim, Murat
    Comert, Melda
    Ayli, Meltem
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2024, 34 (04): : 175 - 183
  • [33] IGF1 deficiency in newly diagnosed Graves’ disease patients
    Martin S.
    Sirbu A.
    Betivoiu M.
    Florea S.
    Barbu C.
    Fica S.
    Hormones, 2015, 14 (4) : 651 - 659
  • [34] Statins Decrease the Risk of Orbitopathy in Newly Diagnosed Patients with Graves Disease
    Nilsson, Anton
    Tsoumani, Kleoniki
    Planck, Tereza
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (05): : 1325 - 1332
  • [35] A longitudinal study of markers of bone turnover in Graves' disease and their value in predicting bone mineral density
    Siddiqi, A
    Burrin, JM
    Noonan, K
    James, I
    Wood, DF
    Price, CP
    Monson, JP
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (03): : 753 - 759
  • [36] IGF1 deficiency in newly diagnosed Graves' disease patients
    Martin, Sorina
    Sirbu, Anca
    Betivoiu, Minodora
    Florea, Suzana
    Barbu, Carmen
    Fica, Simona
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2015, 14 (04): : 651 - 659
  • [37] Risk Factors and Prognosis of Extramedullary Disease in Newly-Diagnosed Multiple Myeloma Patients
    Gunes, Ebru Kilic
    Bulduk, Tuba
    Dumludag, Burak
    Zengin, Haydar
    Yildirim, Murat
    Comert, Melda
    Ayli, Meltem
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S167 - S168
  • [38] MANAGEMENT OF THE PATIENT WITH NEWLY-DIAGNOSED PARKINSONS-DISEASE
    PAULSON, GW
    GERIATRICS, 1993, 48 (02) : 30 - &
  • [39] Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease
    Kim, Jinyoung
    Choi, Min Sun
    Park, Jun
    Park, Hyunju
    Jang, Hye Won
    Choe, Jun-Ho
    Kim, Jung-Han
    Kim, Jee Soo
    Cho, Young Seok
    Choi, Joon Young
    Kim, Tae Hyuk
    Chung, Jae Hoon
    Kim, Sun Wook
    THYROID, 2021, 31 (08) : 1264 - 1271
  • [40] The diagnostic criteria of Graves' disease and especially the thyrotropin receptor antibody; our own experience
    Paunkovic, Nebojsa
    Paunkovic, Jane
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2007, 10 (02): : 89 - 94
12345